WuXi XDC

Will you be attending the 15th annual World ADC Event Series in SAN DIEGO during Nov. 4-7? We’ll be at Booth #310 to showcase our integrated CRDMO services for Bioconjugate, Dr. Marie Z. , CTO of WuXi XDC, will give a speech on “Accelerating Novel ADC Development through WuXi XDC’s Innovation Technology and Integrated Development/Manufacturing Platform” on Tuesday, November 5th, 5:30 pm PST. Look forward to seeing you there! Schedule a meeting with us: https://lnkd.in/guvvwrnY

Meet us at Booth #D35 during BioJapan 2024 at PACIFICO Yokohama, Japan, for an engaging discussion and conversation with our team. Excitingly, our expert Dr. Jun Hu, Head of Client Enabling Center of Excellence of WuXi XDC will join forces with Feng Xu, CMC Associate Director of WuXi Biologics, to present a talk on "IND-enabling Platform for R&D, Manufacturing of Abs and ADC" at 4:10PM JST, October 9th. They will share their valuable insights and experiences in enabling Abs and ADCs through cutting-edge platforms. We look forward to connecting with you at Bio Japan 2024! Register now to secure your spot and schedule a meeting with us: https://lnkd.in/guvvwrnY

Join us for a compelling panel discussion themed “Accelerate ADC and Bioconjugates Development” during the Festival of Biologics (October 15-17) in Basel, Switzerland! We are very honored to have Ulf Grawunder, Co-founder and CEO of T-CURX, as the panel moderator, and Jack Elands, CEO of Adcytherix SAS, Christian Klein, Dept. Head of Roche Pharmaceutical Research and Early Development, and Dragan Grabulovski, CEO of Araris Biotech, along with Dr. Jimmy L. , CEO of WuXi XDC, as panelists. Join us to explore the diversified development prospects from ADC to XDC and strategies to accelerate the development of bioconjugates. Look forward to seeing you there! Schedule a meeting with us: https://lnkd.in/guvvwrnY

DAR analysis is a critical aspect of the development of ADC and Bioconjugates, and it significantly influences the efficacy and safety of the Bioconjugates. An optimal DAR can maximize the drug's therapeutic benefits while minimizing side effects. At WuXi XDC, various DAR analytical methods can be provided according to the molecules, including MS, UV, HILIC, RP, HIC, ensuring precise and comprehensive DAR determination for your Bioconjugates’ development needs. Explore our analytical capabilities here: https://lnkd.in/gHFF4Kub

📣 Last minute to register the insightful webinar "Accelerating ADC Drug Development with Technology Innovation and Integrated Platform". During this session, Dr. Bingquan (Stuart) Wang, a Senior Director of US-EU CMC Management at WuXi XDC with extensive CMC experiences in ADC and bioconjugation field, will delve into how to overcome hurdles with advanced CMC expertise and innovative technologies.   Key Takeaways: 💡 Facing main challenges across the ADC field. 💡 Learning strategies to overcome these challenges. 💡 Discovering how to accelerate CMC development for IND. 💡 Understanding strategies to accelerate BLA development. 💡 Analyzing case studies.   Find more info and to register for this webinar: https://lnkd.in/gRi7qUzV

Attending the CPHI Milan (October 8-10) in Italy? Our experts will be there at booth #3G-130 to discuss your outsourcing or partnering needs. Schedule a meeting: https://lnkd.in/guvvwrnY

Will you be attending the Festival of Biologics (October 15-17) in Basel, Switzerland? Visit us at Booth #1128 to learn more about our state-of-the-art CRDMO capabilities for Bioconjugates. Dr. Jimmy L., CEO of WuXi XDC, will be speaking on Tuesday, Oct.15th at 10:00 am CET to present insights into the topic "Accelerate ADC Development From DNA to BLA Through Fully Integrated CMC and Manufacturing Platforms". Contact us and we'll set up a convenient time to discuss your outsourcing or partnering needs. Request a meeting: https://lnkd.in/guvvwrnY

Join us on Thursday, Sep.26th at 10AM EST for a webinar on "Accelerating ADC Drug Development with Technology Innovation and Integrated Platform". During this session, Dr. Bingquan (Stuart) Wang, a Senior Director of US-EU CMC Management at WuXi XDC with extensive CMC experiences in ADC and bioconjugation field, will delve into how to overcome hurdles with advanced CMC expertise and innovative technologies. Key Takeaways: 💡 Facing main challenges across the ADC field. 💡 Learning strategies to overcome these challenges. 💡 Discovering how to accelerate CMC development for IND. 💡 Understanding strategies to accelerate BLA development. 💡 Analyzing case studies. Register for this webinar: https://lnkd.in/gRi7qUzV

Will you be attending the BioJapan 2024 during October 9th -11th at PACIFICO Yokohama, Japan? Dr. Jimmy L., CEO of WuXi XDC, will be speaking on Thursday, Oct.10th at 4PM JST to present insights into the topic "Accelerate ADC CMC Development and commercialization with WuXi XDC's Fully Integrated CRDMO Services". Our team will also be available at Booth #D35 to dive into discussions with you on how our innovative technology and integrated CRDMO solutions can advance your bioconjugate journey. Schedule a meeting: https://lnkd.in/guvvwrnY

We are thrilled to announce that WuXi XDC has been shortlisted in three categories for the prestigious 11th World ADC Awards: ⭐ Best ADC Platform Technology ⭐ Best Contract Research Organization ⭐ Best Contract Manufacturing Development Organization We are deeply grateful for the recognition, and will remain empowering our clients with enhanced CRDMO services to drive the future of Bioconjugates forward.